BIM
AMPH icon

Bogle Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bogle Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-33,430
Closed -$615K – 303
2016
Q4 		$615K Sell
33,430
-332,173
-91% -$6.46M 0.04% 282
2016
Q3 		$6.93M Buy
365,603
+248,256
+212% +$4.51M 0.5% 76
2016
Q2 		$1.89M Buy
+117,347
New +$1.66M 0.13% 183
2014
Q4 		– Sell
-52,729
Closed -$614K – 353
2014
Q3 		$614K Buy
+52,729
New +$549K 0.04% 279

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bogle Investment Management's AMPH Position: Q1 2017 in Review

Bogle Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2017, closing a stake of 33,430 shares — an estimated $615K sold.

Bogle Investment Management first reported a position in AMPH in Q3 2014 and held it in 4 quarters. The position peaked at $6.93M in Q3 2016. 116 funds tracked by Wall St. Rank hold AMPH as of Q1 2017.

  • Bogle Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Bogle Investment Management sold 33,430 Amphastar Pharmaceuticals shares in Q1 2017, an estimated $615K.
  • Bogle Investment Management first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 4 quarters.
  • Bogle Investment Management's Amphastar Pharmaceuticals position peaked at $6.93M in Q3 2016.
  • 116 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2017.

Based on Bogle Investment Management's 13F filing for Q1 2017, filed 12 May 2017.